Full US approval goes to diabetic retinopathy drug Luncentis

The monthly ranibizumab injection has now been approved to treat all forms of diabetic retinopathy after the US Food and Drug Administration (FDA) gave it the stamp of approval. (read more)

Wearable sweat sensor may help diagnose diabetes and cystic fibrosis

Wearable technology is coming up and how! From fitness bands to smart eyewear, every other day there seems to be news of some new product with spectacular features. Coming to healthcare too, researchers from US – Stanford University, in collaboration with the University of California, Berkeley – have developed a wristband-type wearable sweat sensor that could help diagnose cystic fibrosis, diabetes and other diseases. Who knew that a little amount of sweat could reveal so much about your health! The sensor is said to collect sweat, measures its molecular constituents and then electronically transmits the results for analysis and diagnostics through a smartphone, Xinhua news agency reported on Monday. (read more)

Science may have found a way to reserve type 1 diabetes

A diagnosis of type 1 diabetes means a lifetime of constant diligence. Unlike type 2 diabetes, type 1 is the kind patients are born with. They have to check blood sugar several times a day and take insulin as needed; the process is difficult, expensive, and potentially dangerous. That helps explain the excitement about a potential cure for type 1 diabetes using an already approved treatment. (read more)